Literature DB >> 12605223

Observing the invisible: successful tumor immunity in humans.

Robert B Darnell, Jerome B Posner.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12605223     DOI： 10.1038/ni0303-201

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  14 in total

1.  Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers.

Authors:  Brigitte Gückel; Christine Rentzsch; Maria-Dorothea Nastke; Alexander Marmé; Ines Gruber; Stefan Stevanović; Simone Kayser; Diethelm Wallwiener
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-22       Impact factor: 4.553

Review 2.  RNA protein interaction in neurons.

Authors:  Robert B Darnell
Journal:  Annu Rev Neurosci       Date:  2013-05-20       Impact factor: 12.449

3.  Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

Authors:  Mayu O Frank; Julia Kaufman; Suyan Tian; Mayte Suárez-Fariñas; Salina Parveen; Nathalie E Blachère; Michael J Morris; Susan Slovin; Howard I Scher; Matthew L Albert; Robert B Darnell
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

Review 4.  The invisible arm of immunity in common cancer chemoprevention agents.

Authors:  Edmond Marzbani; Carol Inatsuka; Hailing Lu; Mary L Disis
Journal:  Cancer Prev Res (Phila)       Date:  2013-08

5.  Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells.

Authors:  Wendy K Roberts; Ilana J Deluca; Ashby Thomas; John Fak; Travis Williams; Noreen Buckley; Athanasios G Dousmanis; Jerome B Posner; Robert B Darnell
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

Review 6.  Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.

Authors:  Lidia M Yshii; Reinhard Hohlfeld; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2017-11-06       Impact factor: 42.937

7.  A T-cell receptor associated with naturally occurring human tumor immunity.

Authors:  Bianca D Santomasso; Wendy K Roberts; Ashby Thomas; Travis Williams; Nathalie E Blachère; Mark E Dudley; Alan N Houghton; Jerome B Posner; Robert B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

8.  Treatment options in paraneoplastic disorders of the peripheral nervous system.

Authors:  Jean-Christophe Antoine; Jean-Philippe Camdessanché
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

9.  T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.

Authors:  Nathalie E Blachère; Dana E Orange; Bianca D Santomasso; Jessica Doerner; Patricia K Foo; Margaret Herre; John Fak; Sébastien Monette; Emily C Gantman; Mayu O Frank; Robert B Darnell
Journal:  Eur J Immunol       Date:  2014-11       Impact factor: 5.532

10.  No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.

Authors:  Janet W de Beukelaar; Georges M Verjans; Yvette van Norden; Johannes C Milikan; Jaco Kraan; Herbert Hooijkaas; Kees Sintnicolaas; Jan W Gratama; Peter A Sillevis Smitt
Journal:  Cancer Immunol Immunother       Date:  2007-02-14       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.